JAMA Network Open-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2267198, encodeId=ef26226e198ce, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：风险预测 经验分享：预测模型的，7天被拒，我还以为起码送个外审，明明说了初次决定中位时间是2天的，搞的我还期待了一下...尽力了，课题组只有这个质量的临床数据，预测模型的方法学也没啥大的可以创新了。投scientific reports去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8c8172690, createdName=ms4000002103338271, createdTime=Thu May 29 15:23:08 CST 2025, time=2025-05-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2266802, encodeId=3e2b226680286, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：anesthesiaology 经验分享：刚投完，等结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac19605763, createdName=ms4000001900358508, createdTime=Tue May 27 08:45:05 CST 2025, time=2025-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2264927, encodeId=f9e1226492ea7, content=投稿命中率:50.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb2f8675193, createdName=ms1000001346763102, createdTime=Wed May 14 00:55:05 CST 2025, time=2025-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=622, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=)]

2025-05-29 ms4000002103338271 来自北京

审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向：风险预测
经验分享：预测模型的，7天被拒，我还以为起码送个外审，明明说了初次决定中位时间是2天的，搞的我还期待了一下...尽力了，课题组只有这个质量的临床数据，预测模型的方法学也没啥大的可以创新了。投scientific reports去了。

6 0

[GetPortalCommentsPageByObjectIdResponse(id=2267198, encodeId=ef26226e198ce, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：风险预测 经验分享：预测模型的，7天被拒，我还以为起码送个外审，明明说了初次决定中位时间是2天的，搞的我还期待了一下...尽力了，课题组只有这个质量的临床数据，预测模型的方法学也没啥大的可以创新了。投scientific reports去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8c8172690, createdName=ms4000002103338271, createdTime=Thu May 29 15:23:08 CST 2025, time=2025-05-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2266802, encodeId=3e2b226680286, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：anesthesiaology 经验分享：刚投完，等结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac19605763, createdName=ms4000001900358508, createdTime=Tue May 27 08:45:05 CST 2025, time=2025-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2264927, encodeId=f9e1226492ea7, content=投稿命中率:50.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb2f8675193, createdName=ms1000001346763102, createdTime=Wed May 14 00:55:05 CST 2025, time=2025-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=622, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=)]

2025-05-27 ms4000001900358508 来自辽宁省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：anesthesiaology
经验分享：刚投完，等结果

8 0

[GetPortalCommentsPageByObjectIdResponse(id=2267198, encodeId=ef26226e198ce, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：风险预测 经验分享：预测模型的，7天被拒，我还以为起码送个外审，明明说了初次决定中位时间是2天的，搞的我还期待了一下...尽力了，课题组只有这个质量的临床数据，预测模型的方法学也没啥大的可以创新了。投scientific reports去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8c8172690, createdName=ms4000002103338271, createdTime=Thu May 29 15:23:08 CST 2025, time=2025-05-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2266802, encodeId=3e2b226680286, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：anesthesiaology 经验分享：刚投完，等结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac19605763, createdName=ms4000001900358508, createdTime=Tue May 27 08:45:05 CST 2025, time=2025-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2264927, encodeId=f9e1226492ea7, content=投稿命中率:50.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb2f8675193, createdName=ms1000001346763102, createdTime=Wed May 14 00:55:05 CST 2025, time=2025-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=622, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=)]

2025-05-14 ms1000001346763102 来自山东省

投稿命中率:50.0
经验分享：挺快的

11 0

[GetPortalCommentsPageByObjectIdResponse(id=2267198, encodeId=ef26226e198ce, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：风险预测 经验分享：预测模型的，7天被拒，我还以为起码送个外审，明明说了初次决定中位时间是2天的，搞的我还期待了一下...尽力了，课题组只有这个质量的临床数据，预测模型的方法学也没啥大的可以创新了。投scientific reports去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8c8172690, createdName=ms4000002103338271, createdTime=Thu May 29 15:23:08 CST 2025, time=2025-05-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2266802, encodeId=3e2b226680286, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：anesthesiaology 经验分享：刚投完，等结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac19605763, createdName=ms4000001900358508, createdTime=Tue May 27 08:45:05 CST 2025, time=2025-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2264927, encodeId=f9e1226492ea7, content=投稿命中率:50.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb2f8675193, createdName=ms1000001346763102, createdTime=Wed May 14 00:55:05 CST 2025, time=2025-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=622, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=)]

2025-04-22 ms6000000839895533 来自加利福尼亚

审稿速度:24.0 | 投稿命中率:25.0
经验分享：难啊

16 0

[GetPortalCommentsPageByObjectIdResponse(id=2267198, encodeId=ef26226e198ce, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：风险预测 经验分享：预测模型的，7天被拒，我还以为起码送个外审，明明说了初次决定中位时间是2天的，搞的我还期待了一下...尽力了，课题组只有这个质量的临床数据，预测模型的方法学也没啥大的可以创新了。投scientific reports去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8c8172690, createdName=ms4000002103338271, createdTime=Thu May 29 15:23:08 CST 2025, time=2025-05-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2266802, encodeId=3e2b226680286, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：anesthesiaology 经验分享：刚投完，等结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac19605763, createdName=ms4000001900358508, createdTime=Tue May 27 08:45:05 CST 2025, time=2025-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2264927, encodeId=f9e1226492ea7, content=投稿命中率:50.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb2f8675193, createdName=ms1000001346763102, createdTime=Wed May 14 00:55:05 CST 2025, time=2025-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=622, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=)]

2025-04-07 ms1000001393535737 来自湖北省

拒稿
Start Date
Review Complete - Decision Processed 04-07-2025 09:27
Under Review 03-31-2025 14:41
In Quality Control 03-31-2025 09:20
Submission Pending 03-30-2025 23:00

24 0

[GetPortalCommentsPageByObjectIdResponse(id=2267198, encodeId=ef26226e198ce, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：风险预测 经验分享：预测模型的，7天被拒，我还以为起码送个外审，明明说了初次决定中位时间是2天的，搞的我还期待了一下...尽力了，课题组只有这个质量的临床数据，预测模型的方法学也没啥大的可以创新了。投scientific reports去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8c8172690, createdName=ms4000002103338271, createdTime=Thu May 29 15:23:08 CST 2025, time=2025-05-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2266802, encodeId=3e2b226680286, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：anesthesiaology 经验分享：刚投完，等结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac19605763, createdName=ms4000001900358508, createdTime=Tue May 27 08:45:05 CST 2025, time=2025-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2264927, encodeId=f9e1226492ea7, content=投稿命中率:50.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb2f8675193, createdName=ms1000001346763102, createdTime=Wed May 14 00:55:05 CST 2025, time=2025-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=622, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=)]

2025-02-28 1057541_1346 来自上海

审稿速度:2.0 | 投稿命中率:5.0
偏重的研究方向：健康公平
经验分享：焦急等待中

38 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267198, encodeId=ef26226e198ce, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：风险预测 经验分享：预测模型的，7天被拒，我还以为起码送个外审，明明说了初次决定中位时间是2天的，搞的我还期待了一下...尽力了，课题组只有这个质量的临床数据，预测模型的方法学也没啥大的可以创新了。投scientific reports去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8c8172690, createdName=ms4000002103338271, createdTime=Thu May 29 15:23:08 CST 2025, time=2025-05-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2266802, encodeId=3e2b226680286, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：anesthesiaology 经验分享：刚投完，等结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac19605763, createdName=ms4000001900358508, createdTime=Tue May 27 08:45:05 CST 2025, time=2025-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2264927, encodeId=f9e1226492ea7, content=投稿命中率:50.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb2f8675193, createdName=ms1000001346763102, createdTime=Wed May 14 00:55:05 CST 2025, time=2025-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=622, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=)]

2025-03-25 ms8000000722006726 来自江西省

偏重的研究方向：公共卫生;运动康复
经验分享：In Quality Control 3.24
Under Review 3.25

26 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267198, encodeId=ef26226e198ce, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：风险预测 经验分享：预测模型的，7天被拒，我还以为起码送个外审，明明说了初次决定中位时间是2天的，搞的我还期待了一下...尽力了，课题组只有这个质量的临床数据，预测模型的方法学也没啥大的可以创新了。投scientific reports去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8c8172690, createdName=ms4000002103338271, createdTime=Thu May 29 15:23:08 CST 2025, time=2025-05-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2266802, encodeId=3e2b226680286, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：anesthesiaology 经验分享：刚投完，等结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac19605763, createdName=ms4000001900358508, createdTime=Tue May 27 08:45:05 CST 2025, time=2025-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2264927, encodeId=f9e1226492ea7, content=投稿命中率:50.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb2f8675193, createdName=ms1000001346763102, createdTime=Wed May 14 00:55:05 CST 2025, time=2025-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=622, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=)]

2025-03-06 ms4000001428066077 来自北京

问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中

30 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267198, encodeId=ef26226e198ce, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：风险预测 经验分享：预测模型的，7天被拒，我还以为起码送个外审，明明说了初次决定中位时间是2天的，搞的我还期待了一下...尽力了，课题组只有这个质量的临床数据，预测模型的方法学也没啥大的可以创新了。投scientific reports去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8c8172690, createdName=ms4000002103338271, createdTime=Thu May 29 15:23:08 CST 2025, time=2025-05-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2266802, encodeId=3e2b226680286, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：anesthesiaology 经验分享：刚投完，等结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac19605763, createdName=ms4000001900358508, createdTime=Tue May 27 08:45:05 CST 2025, time=2025-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2264927, encodeId=f9e1226492ea7, content=投稿命中率:50.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb2f8675193, createdName=ms1000001346763102, createdTime=Wed May 14 00:55:05 CST 2025, time=2025-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=622, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=)]

2024-10-11 ms7000000384438036 来自山东省

偏重的研究方向：公共卫生
经验分享：10-7 submission pending, in quality control, under review
感觉自己写的很差，开个帖记录一下多久会被拒稿

83 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267198, encodeId=ef26226e198ce, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：风险预测 经验分享：预测模型的，7天被拒，我还以为起码送个外审，明明说了初次决定中位时间是2天的，搞的我还期待了一下...尽力了，课题组只有这个质量的临床数据，预测模型的方法学也没啥大的可以创新了。投scientific reports去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8c8172690, createdName=ms4000002103338271, createdTime=Thu May 29 15:23:08 CST 2025, time=2025-05-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2266802, encodeId=3e2b226680286, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：anesthesiaology 经验分享：刚投完，等结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac19605763, createdName=ms4000001900358508, createdTime=Tue May 27 08:45:05 CST 2025, time=2025-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2264927, encodeId=f9e1226492ea7, content=投稿命中率:50.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb2f8675193, createdName=ms1000001346763102, createdTime=Wed May 14 00:55:05 CST 2025, time=2025-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=622, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=)]

2022-07-10 ms6000000512079400

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤
经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗

622 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务